BR112019009529A2 - novos derivados de quinolina - Google Patents

novos derivados de quinolina Download PDF

Info

Publication number
BR112019009529A2
BR112019009529A2 BR112019009529A BR112019009529A BR112019009529A2 BR 112019009529 A2 BR112019009529 A2 BR 112019009529A2 BR 112019009529 A BR112019009529 A BR 112019009529A BR 112019009529 A BR112019009529 A BR 112019009529A BR 112019009529 A2 BR112019009529 A2 BR 112019009529A2
Authority
BR
Brazil
Prior art keywords
compounds
quinoline derivatives
new quinoline
preparing
pharmaceutical compositions
Prior art date
Application number
BR112019009529A
Other languages
English (en)
Inventor
Köhler Adeline
Böhm Claudia
Welz Claudia
Kulke Daniel
Schwarz Hans-Georg
Köbberling Johannes
Börngen Kirsten
Hink Maike
Lindner Niels
Griebenow Nils
Ilg Thomas
Görgens Ulrich
Hübsch Walter
Zhuang Wei
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of BR112019009529A2 publication Critical patent/BR112019009529A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

novos derivados de quinolina. a presente invenção aborda novos compostos da fórmula geral (i): (i), em que a, r1, r2, r3, r4, r5, r6 e q são como aqui definidos, métodos para preparar os referidos compostos, compostos intermediários úteis para preparar os referidos compostos, composições farmacêuticas e combinações compreendendo os referidos compostos e o uso dos referidos compostos para fabricar composições farmacêuticas para tratamento, controle e/ou prevenção de doenças, em particular de infecções de helmintos, como um agente único ou em combinação com outros ingredientes ativos.
BR112019009529A 2016-11-11 2017-11-06 novos derivados de quinolina BR112019009529A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16198550 2016-11-11
PCT/EP2017/078319 WO2018087036A1 (en) 2016-11-11 2017-11-06 New anthelmintic quinoline-3-carboxamide derivatives

Publications (1)

Publication Number Publication Date
BR112019009529A2 true BR112019009529A2 (pt) 2019-07-30

Family

ID=57321155

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019009529A BR112019009529A2 (pt) 2016-11-11 2017-11-06 novos derivados de quinolina

Country Status (27)

Country Link
US (2) US10889573B2 (pt)
EP (1) EP3538512B1 (pt)
JP (1) JP7165129B2 (pt)
KR (1) KR102595730B1 (pt)
CN (1) CN109890793B (pt)
AU (1) AU2017357503B2 (pt)
BR (1) BR112019009529A2 (pt)
CA (1) CA3043298A1 (pt)
CL (1) CL2019001292A1 (pt)
CO (1) CO2019004776A2 (pt)
DK (1) DK3538512T3 (pt)
DO (1) DOP2019000117A (pt)
ES (1) ES2884073T3 (pt)
IL (1) IL266407B (pt)
MX (1) MX2019005569A (pt)
MY (1) MY196327A (pt)
NZ (1) NZ752550A (pt)
PH (1) PH12019501034A1 (pt)
PL (1) PL3538512T3 (pt)
PT (1) PT3538512T (pt)
SG (1) SG11201903059SA (pt)
SI (1) SI3538512T1 (pt)
TW (1) TWI821165B (pt)
UA (1) UA126119C2 (pt)
UY (1) UY37480A (pt)
WO (1) WO2018087036A1 (pt)
ZA (1) ZA201903708B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019015895A (es) 2017-06-30 2020-02-07 Bayer Animal Health Gmbh Nuevos derivados de azaquinolina.
US11254661B2 (en) * 2017-08-04 2022-02-22 Bayer Animal Health Gmbh Quinoline derivatives for treating infections with helminths
CA3085675A1 (en) 2017-12-15 2019-06-20 Bayer Animal Health Gmbh Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives
BR112020022619A2 (pt) * 2018-05-09 2021-02-02 Bayer Animal Health Gmbh novos derivados de quinolina
EP3643711A1 (en) * 2018-10-24 2020-04-29 Bayer Animal Health GmbH New anthelmintic compounds
US20220064159A1 (en) * 2018-12-18 2022-03-03 Elanco Tiergesundheit Ag Bicyclic derivatives
US20220064160A1 (en) * 2018-12-18 2022-03-03 Elanco Tiergesundheit Ag Bicyclic derivatives
CN113825543A (zh) 2019-03-19 2021-12-21 勃林格殷格翰动物保健美国公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
US20220242857A1 (en) * 2019-06-07 2022-08-04 Elanco Tiergesundheit Ag Bicyclic derivatives for treating endoparasites
TW202120490A (zh) * 2019-07-30 2021-06-01 德商拜耳動物保健有限公司 新穎異喹啉衍生物
BR112022012126A2 (pt) 2019-12-18 2022-08-30 Intervet Int Bv Compostos antelmínticos compreendendo uma estrutura quinolínica
BR112022020315A2 (pt) 2020-04-09 2022-12-13 Bayer Animal Health Gmbh Novos compostos anti-helmínticos
MX2022015038A (es) 2020-05-29 2023-01-04 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos.
US20240059680A1 (en) 2020-11-18 2024-02-22 Elanco Tiergesundheit Ag N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
TW202237600A (zh) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 雙環衍生物
EP4259606A1 (en) 2020-12-11 2023-10-18 Intervet International B.V. Anthelmintic compounds comprising a pyridine structure
AU2021395477A1 (en) 2020-12-11 2023-06-22 Intervet International B.V. Anthelmintic compounds comprising a thienopyridine structure
EP4148052A1 (en) 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
AR127495A1 (es) 2021-11-01 2024-01-31 Boehringer Ingelheim Vetmedica Gmbh Compuestos de pirrolopiridazina como antihelmínticos

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
KR840000768A (ko) * 1982-07-23 1984-02-27 박이은 무연통의 무연탄 난로
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
RU2394819C2 (ru) 2004-10-20 2010-07-20 Кумиай Кемикал Индастри Ко., Лтд. Инсектицид, акарицид и нематоцид, содержащие в качестве активного компонента производное 3-триазолилфенилсульфида
WO2006103120A2 (en) * 2005-04-01 2006-10-05 Insa Rouen New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
ES2550398T3 (es) 2005-10-06 2015-11-06 Nippon Soda Co., Ltd. Compuestos de amina cíclica reticulados y agentes para el control de plagas
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び/または予防剤
EP2164328B8 (en) 2007-06-08 2013-09-11 Dart Neuroscience (Cayman) Ltd Therapeutic pyrazoloquinoline urea derivatives
JP5268461B2 (ja) 2008-07-14 2013-08-21 Meiji Seikaファルマ株式会社 Pf1364物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
WO2010066780A1 (en) 2008-12-12 2010-06-17 Syngenta Participations Ag Spiroheterocyclic n-oxypiperidines as pesticides
CN102574817A (zh) * 2009-09-24 2012-07-11 巴斯夫欧洲公司 用于抵抗无脊椎动物害虫的氨基喹唑啉化合物
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
BR112012030408A2 (pt) 2010-05-31 2015-09-29 Syngenta Participations Ag método de melhoramento de culturas
EP2984930B1 (en) 2010-08-31 2018-10-03 Meiji Seika Pharma Co., Ltd. Pest control agent
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
US8791162B2 (en) 2011-02-14 2014-07-29 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
MX2014006317A (es) * 2011-11-28 2014-06-23 Du Pont Derivados de n-(4-quinolinilmetil) sulfonamida y su uso como antihelminticos.
WO2013096151A1 (en) 2011-12-22 2013-06-27 Glaxosmithkline Llc Chemical compounds
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
AR089939A1 (es) 2012-02-09 2014-10-01 Glenmark Pharmaceuticals Sa COMPUESTOS BICICLICOS COMO INHIBIDORES DE mPGES-1
US9334238B2 (en) 2012-03-30 2016-05-10 Basf Se N-substituted pyridinylidenes for combating animal pests
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
BR112014026746A2 (pt) 2012-04-27 2017-06-27 Dow Agrosciences Llc composições pesticidas e processos relacionados com as mesmas
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
BR112015014909A2 (pt) * 2012-12-20 2017-07-11 Bayer Cropscience Ag derivados de sulfureto de arilo e de sulfóxido de arilo como acaricidas e inseticidas
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
US20160081342A1 (en) 2013-05-23 2016-03-24 Syngenta Participations Ag Tank-mix formulations
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
CN105636440A (zh) 2013-10-17 2016-06-01 美国陶氏益农公司 制备杀虫化合物的方法
KR20160072154A (ko) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
RU2695815C9 (ru) * 2014-03-24 2019-10-28 Гуандун Чжуншэн Фармасьютикал Ко., Лтд Хинолиновые производные в качестве ингибиторов smo
WO2016005276A1 (en) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Process for preparing fluorinated iminopyridine compounds
KR101961581B1 (ko) 2015-02-17 2019-03-22 닛뽕소다 가부시키가이샤 농약 조성물
KR20180095580A (ko) 2015-12-17 2018-08-27 아스텍스 테라퓨틱스 리미티드 H-pgds 억제제로서의 퀴놀린-3-카르복스아미드

Also Published As

Publication number Publication date
CN109890793B (zh) 2022-11-18
MX2019005569A (es) 2019-09-05
EP3538512B1 (en) 2021-06-16
US20210115026A1 (en) 2021-04-22
DK3538512T3 (da) 2021-07-05
RU2019117917A (ru) 2020-12-11
PT3538512T (pt) 2021-08-16
JP2019535706A (ja) 2019-12-12
SI3538512T1 (sl) 2021-09-30
TWI821165B (zh) 2023-11-11
AU2017357503B2 (en) 2022-02-17
NZ752550A (en) 2023-03-31
US11505545B2 (en) 2022-11-22
WO2018087036A1 (en) 2018-05-17
UY37480A (es) 2018-06-29
ZA201903708B (en) 2022-11-30
US10889573B2 (en) 2021-01-12
CN109890793A (zh) 2019-06-14
CO2019004776A2 (es) 2019-07-31
RU2019117917A3 (pt) 2021-03-05
SG11201903059SA (en) 2019-05-30
KR20190076980A (ko) 2019-07-02
IL266407B (en) 2021-10-31
IL266407A (en) 2019-06-30
PL3538512T3 (pl) 2021-11-22
CA3043298A1 (en) 2018-05-17
MY196327A (en) 2023-03-24
TW201829384A (zh) 2018-08-16
KR102595730B1 (ko) 2023-10-27
EP3538512A1 (en) 2019-09-18
DOP2019000117A (es) 2019-05-31
UA126119C2 (uk) 2022-08-17
PH12019501034A1 (en) 2019-12-02
ES2884073T3 (es) 2021-12-10
AU2017357503A1 (en) 2019-05-02
JP7165129B2 (ja) 2022-11-02
US20200024264A1 (en) 2020-01-23
CL2019001292A1 (es) 2019-09-27

Similar Documents

Publication Publication Date Title
BR112019009529A2 (pt) novos derivados de quinolina
BR112019008458A2 (pt) 1,2,4-triazolonas 2,4,5-trisubstituídas.
CO2020001244A2 (es) Derivados de quinolina para tratar infecciones con helmintos
CO2018010966A2 (es) Nuevos derivados de pirazolopirimidina
CO2019014484A2 (es) Nuevos derivados de azaquinolina
BR112015028879A8 (pt) compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
BR112017023764A2 (pt) derivados de ciclohexano substituído por amido
CO2021005226A2 (es) Nuevos compuestos antihelmínticos
BR112017002221A2 (pt) 2-(morfolin-4-il)-1,7-naftiridinas
BR112022001567A2 (pt) Derivados de isoquinolina e seu uso para o tratamento de infecções parasitárias.
CO2020013876A2 (es) Nuevos derivados de quinolina
BR112022010112A2 (pt) Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica
UY37250A (es) Derivados macrocíclicos de indol
DOP2019000275A (es) Nuevos derivados de pirazol bicíclicos
BR112018074381A2 (pt) [8-(fenil sulfonil)-3,8-diazabiciclo[3.2.1]oct-3-il] (1h-1,2,3-triazol-4-il)metanonas
UY37973A (es) Derivados de indol macrocíclicos
EA202090448A1 (ru) Дигидрооксадиазиноны
BR112023019030A2 (pt) Derivados de fósforo como inibidores de sos1
BR112018070064A2 (pt) composições farmacêuticas estáveis para administração tópica e uso das mesmas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI N? 10196/2001, QUE MODIFICOU A LEI N? 9279/96, A CONCESS?O DA PATENTE EST? CONDICIONADA ? ANU?NCIA PR?VIA DA ANVISA. CONSIDERANDO A APROVA??O DOS TERMOS DO PARECER N? 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL N? 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVID?NCIAS CAB?VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]